Related Experiment Video
Updated: Feb 14, 2026

05:57
Platelet-Rich Plasma Lysate for Treatment of Eye Surface Diseases
Published on: August 2, 2022
5.1K
Platelet-rich plasma for the spinal fusion
Moon Soo Park1, Seong-Hwan Moon2, Tae-Hwan Kim1
11 Department of Orthopaedic Surgery, Medical College of Hallym University, Gyeonggi-do, Republic of Korea.
Journal of Orthopaedic Surgery (Hong Kong)
|February 9, 2018
Summary
Platelet-rich plasma (PRP) shows mixed results for spinal fusion enhancement in animal and human studies. Higher platelet counts and growth factor concentrations may be key to promoting spinal fusion.
Area of Science:
- Orthopedics
- Regenerative Medicine
- Biomaterials
Background:
- Platelet-rich plasma (PRP) is investigated for enhancing spinal fusion.
- Existing reviews focus solely on clinical data, lacking comprehensive analysis of animal models and PRP composition.
Purpose of the Study:
- To review literature on PRP's effect on spinal fusion in both animal models and clinical studies.
- To analyze the impact of platelet count and growth factor concentration in PRP on spinal fusion outcomes.
Main Methods:
- A PubMed search identified relevant English-language articles.
- Included 16 case-control or prospective randomized studies on spinal fusion.
- Categorized studies into small-sized animal, middle-sized animal, and clinical models.
Main Results:
- Studies reported both beneficial and inhibitory effects of PRP on spinal fusion.
- No definitive conclusion was reached regarding PRP's general stimulating effect on spinal fusion.
- Potential for PRP to promote human spinal fusion exists if platelet count or growth factor concentration is increased.
Conclusions:
- The efficacy of PRP for spinal fusion is inconclusive and may depend on specific parameters.
- Optimizing platelet count and growth factor concentration in PRP could enhance spinal fusion success.
- Further research is needed to establish PRP's role and optimal preparation for spinal fusion.
Related Concept Videos
Fusion of Secretory Vesicles with the Plasma Membrane
19.0K
Proteins and neurotransmitters in secretory vesicles can be released from a cell upon vesicle docking, priming, and fusion with the plasma membrane. Vesicles are docked and primed in preparation for the quick exocytosis of their contents in response to a stimulus. The fusion process is mainly carried out by a SNAP Receptor or SNARE complex, consisting of synaptobrevin, syntaxin-1, and SNAP-25.
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
In 1993, Jim Rothman proposed that the antiparallel pairing of vesicular and transmembrane SNAREs, or...
19.0K
Nuclear Fusion
33.9K
The process of converting very light nuclei into heavier nuclei is also accompanied by the conversion of mass into large amounts of energy, a process called fusion. The principal source of energy in the sun is a net fusion reaction in which four hydrogen nuclei fuse and ultimately produce one helium nucleus and two positrons.
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
A helium nucleus has a mass that is 0.7% less than that of four hydrogen nuclei; this lost mass is converted into energy during the fusion. This reaction produces about...
33.9K
Structure and Function of Platelets
3.8K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
3.8K
Formation of the Platelet Plug
9.6K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
9.6K
Tagging and Fusion Proteins
8.5K
Proteins are involved in several cellular processes and biochemical reactions. Analyzing a specific protein of interest requires it to be isolated from the other proteins in the cell. This is achieved by overexpressing the specific gene in a suitable host to produce large quantities of the target protein. A tag or label is recombined with the gene to produce a fusion protein containing the target protein and the tag. The tags on these fusion proteins can then be used for easy detection and...
8.5K
SNAREs and Membrane Fusion
12.9K
Once a transport vesicle has recognized its target organelle, the vesicular membrane needs to fuse with the target membrane to unload the cargo. Transmembrane proteins called SNAREs present on organelle membranes and their vesicles, mediate vesicle fusion.
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
SNAREs exist in pairs that symmetrically interact and catalyze the fusion of the lipid bilayers in vesicle and target organelle. v-SNARE in the vesicle membrane are single polypeptide chains that bind to a complementary t-SNARE, composed of 2...
12.9K

